ArticleLiver cancer2021

Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region.

Colby S Shemesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.